API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://endpts.com/royalty-pharma-nabs-475m-milestone-from-pfizer-upon-migraine-nasal-spray-ok/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-nasal-spray-migraine-2023-03-10/
https://www.prnewswire.com/news-releases/us-neurologists-cautiously-optimistic-about-potential-approval-of-pfizers-zavegepant-for-the-acute-treatment-of-migraine-according-to-spherix-global-insights-301758432.html
https://www.prnewswire.com/news-releases/us-fda-accepts-for-review-biohavens-new-drug-application-nda-filing-of-intranasal-zavegepant-for-the-acute-treatment-of-migraine-301552566.html
https://www.fiercebiotech.com/biotech/after-selling-its-blockbuster-migraine-program-can-new-biohaven-strike-gold-twice
https://www.nasdaq.com/articles/biohaven-bhvn-intranasal-migraine-therapy-meets-goal-in-study
https://www.pharmaceutical-technology.com/news/biohaven-pfizer-migraine-drugs/
https://www.prnewswire.com/news-releases/biohaven-receives-fda-may-proceed-letter-to-begin-phase-2-trial-of-intranasal-vazegepant-to-treat-lung-inflammation-after-covid-19-infection-301037998.html